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Vasily V. Ogryzko, R. Louis Schiltz, Valya Russanova, thought to influence functionallydistinct growth regulatory
pathways, allowing the two domains to contribute addi-Bruce H. Howard, and Yoshihiro Nakatani
tively to transformation (Moran, 1993). PCAF (Yang et al.,Laboratory of Molecular Growth Regulation
1996) is associated with p300/CBP and competes withNational Institute of Child Health
E1A for access to it. E1A can disrupt the PCAF-p300/CBPand Human Development
complex and may exert many of its effects on normalNational Institutes of Health
cellular function by this route. Conversely, overexpressionBethesda, Maryland 20892-2753
of PCAF in cultured cells inhibits cell cycle progression
and counteracts the activities of E1A.Summary
A central question in eukaryotic transcription is how
transcription factors gain access to DNA tightly packedp300/CBP is a transcriptional adaptor that integrates
in chromatin. One important mechanism is considered tosignals from many sequence-specific activators via di-
involve histone acetylation. Biochemical studies of tran-rect interactions. Various cellular and viral factors target
scriptionallyactive chromatinhave documented an enrich-p300/CBP to modulate transcription and/or cell cycle
ment of histones acetylated at internal lysines within theirprogression. One such factor, the cellular p300/CBP as-
N-terminal domains, leading to the notion that active chro-sociated factor (PCAF), possesses intrinsic histone ace-
matin is hyperacetylated (reviewed in Turner, 1993; Wolffe,tyltransferase activity. Here, we demonstrate that p300/
1994; Wolffe and Pruss, 1996; Brownell and Allis, 1996).CBP is not only a transcriptional adaptor but also a
Recent findings that histone acetyltransferases are tran-histone acetyltransferase. p300/CBP represents a novel
scriptional cofactors that are recruited onto the specific
class of acetyltransferases in that it does not have the promoters via protein interactions are consistent with tar-
conserved motif found among various other acetyltrans- geted chromatin acetylation (Brownell et al., 1996; Yang
ferases. p300/CBP acetylates all four core histones in et al., 1996). Although mechanisms by which acetylation
nucleosomes. These observations suggest that p300/ of core histones contribute to transcription remain unde-
CBP acetylates nucleosomes in concert with PCAF. fined, acetylation of the histone tails presumably destabi-
lizes the nucleosome, thereby facilitating access by regu-
latory factors.Introduction
The nucleosome core contains 146 bp of DNA in 1.75
turns tightly wrapped around a central histone octamerp300 and CBP are global transcriptional coactivators that
comprising two molecules of each of the core histonesare involved in the regulation of various DNA-binding tran-
(reviewed in Arents and Moudrianakis, 1993; Ramakrish-scriptional factors (for review, see Janknecht and Hunter,
nan, 1994; Pruss et al., 1995). The primary sites of histone1996). p300 and CBP exhibit strong sequence similarity
modification are specific lysine residues of the positivelyand similar functions, such as binding to common DNA-
charged N-terminal tails.At present,GCN5 and PCAFhavebinding transcription factors and viral transformingfactors;
been identified as nuclear histone acetyltransferasesthus, they are considered as functional homologs (re-
(Brownell et al., 1996; Yang et al., 1996). Although allviewed in Eckner et al., 1994; Arany et al., 1995; Lund-
core histones are acetylated in the nucleus (reviewedblad et al., 1995). For this reason, we refer to them as
in Brownell and Allis, 1996), these two enzymes ace-p300/CBP. p300/CBP is a large protein consisting of
tylate only subsets of core histones. PCAF acetylatesover 2400 amino acids, known to interact with a variety
histones H3 and H4, but preferentially H3, in both freeof DNA-binding transcriptional factors including nuclear
histones and mononucleosomes (Yang et al., 1996). Onhormone receptors (Chakravarti et al., 1996; Kamei et
the other hand, human (Yang et al., 1996) and yeast (Kuo
al., 1996), CREB (Chrivia et al., 1993; Kwok et al., 1994;
et al., 1996) GCN5 do not acetylate mononucleosomes
Arany et al., 1995), c-Jun/v-Jun (Arias et al., 1994; Ban-
but only free histones H3 and H4. These results suggest
nister et al., 1995), c-Myb/v-Myb (Dai et al., 1996; Oel- that other histone acetyltransferases and/or regulatory
geschlager et al., 1996), Sap-1a (Janknecht and Nord- subunits for GCN5 and PCAF are involved in histone
heim, 1996), c-Fos (Bannister et al., 1995), and MyoD acetylation in vivo.
(Yuan et al., 1996). DNA-binding factors recruit p300/ In this paper,we demonstrate that p300/CBP possesses
CBP by not only direct but also indirect interactions intrinsic histone acetyltransferase activity. Remarkably,
through cofactors; for example, nuclear hormone recep- p300/CBP acetylates all four core histones in nucleo-
tors recruit p300/CBP directly as well as through indirect somes. These observations imply that p300/CBP is not a
interactions, via SRC-1, which stimulates transcription simple adaptor between DNA-binding factors and P/CAF
by binding to various nuclear hormone receptors (Onate (Yang et al., 1996) or transcription initiation factors (Abra-
et al., 1995; Kamei et al., 1996). ham et al., 1993; Kwok et al., 1994); rather, p300/CBP per
The transforming proteins encoded by small DNA tumor se may contribute directly to transcriptional regulation via
viruses disturb host cell growth control by interacting with targeted acetylation of chromatin.
cellular factors that normally function to repress cell prolif-
eration. E1A-transforming activity resides in two distinct Results
domains, the targets of which include p300/CBP (Eckner
et al., 1994; Arany et al., 1995) and products of the retino- Histone Acetyltransferases That Associate with E1A
blastoma protein (RB) susceptibility gene family (Moran, Although the adenovirus E1A 12S protein (E1A) inhibits
transcription in a variety of genes via direct binding to1993). Interactions of E1A with p300/CBP and RB are
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CBP simultaneously (Yang et al., 1996). Consistent with
this, no PCAF was detected in these fractions by immu-
noblotting (data not shown).
The E1A N-terminus, a region that is not highly con-
served among the various adenovirus serotypes, is in-
volved in p300/CBP binding in vivo. Mutations in the
N-terminal region lead to loss of the capacity for p300/
CBP binding without affecting RB binding (Moran, 1993;
Wang et al., 1993). Next, we tested the requirement of
the E1A N-terminal region for the recruitment of histone
acetyltransferase activity. In contrast to the wild type,
the N-terminal deleted form of E1A (DN-E1A) recruited
only a background level of acetyltransferase activity
(Figure 1A). In agreement with previous reports (Wang
et al., 1993), the DN-E1A showed no ability to interact
with p300/CBP (Figure 1A), although it still retained the
ability to interact with a variety of other polypeptides
including RB (data not shown).
To define the relationship between p300/CBP and
histone acetyltransferase activity, affinity-purified E1A-
binding polypeptides were separated by Mono Q ion-
exchange column. Both p300/CBP and the acetyltrans-
ferase activity were coeluted at 140 mM KCl, while most
of polypeptides were eluted at 260 mM KCl (data not
shown). The active fraction of Mono Q column (z140
mM KCl) was further separated by Superdex-200 gel
filtration column. Both p300/CBP and the acetyltransfer-
Figure 1. Identification of E1A-Associated Histone Acetyltrans- ase activity coeluted after the void volume (Figure 1B),
ferase indicating that p300/CBP is involved in the histone ace-
(A) Twenty microliters of control beads (2), the wild-type (WT), or tyltransferase activity.
the N-terminally deleted (DN) E1A-immobilized beads were incu-
bated with 0.5 ml of HeLa nuclear extract. After washing, the bound
polypeptides were eluted along with FLAG-E1A by incubating with
p300 Is a Histone AcetyltransferaseFLAG-peptide. A 0.05 ml aliquot was used for the filter-binding his-
tone acetyltransferase assay (left). The acetyltransferase activities The results shown in Figure 1 indicate that p300 per se,
are represented by counts of [3H]acetylated histones. Immunoblot- or a polypeptide(s) associated with p300, possesses
ting of affinity-purified polypeptides was done with rabbit polyclonal histone acetyltransferase activity. To test the former
anti-CBP antibody, which cross-reacts with p300 (right). The posi- possibility, the acetyltransferase activity of recombinant
tion of p300/CBP is shown by an arrow.
p300 was measured. p300 was divided into three frag-(B) The active fraction of the Mono Q column was further fractionated
ments (Figure 2A, top), each of which was expressed inby Superdex 200 gel filtration chromatography. The numbers below
the panels indicate the Superdex 200 column fractions assayed. and purified from Sf9 cells via a baculovirus expression
Histone acetyltransferase activity analysis (top) and p300/CBP im- vector. Histone acetyltransferase activity was readily
munoblotting analysis (bottom) are represented as in (A) except that detected in the C-terminal fragment containing amino
a 1 ml aliquot of each fraction was used for the histone acetyltransfer- acids 1135–2414, whereas no activity was found in the
ase assay. The position of p300/CBP is shown by an arrow (bottom).
other fragments (Figure 2A, bottom). Therefore, we con-
clude that p300 per se is a histone acetyltransferase.
p300/CBP (reviewed in Song et al., 1995), E1A also stimu-
lates transcription in some contexts (e.g., see Kitabayashi
et al., 1995). This allowed us to test whether p300/CBP- p300/CBP-Histone Acetyltransferase Domain
To map the histone acetyltransferase domain of p300, abound E1A might recruit histone acetyltransferases or
deacetylases to regulate transcription and subsequently series of deletions was prepared (Figure 2B). Given the
poor conservation of the glutamine-rich region (aa 1815–led to the experiments described below, which reveal that
p300/CBP per se is a histone acetyltransferase. 2414) in the C. elegans p300/CBP homolog (Arany et al.,
1994), the p300 fragment encoding amino acids 1135–Initially, recombinant FLAG-epitope-tagged E1A was
immobilized on anti-FLAG antibody beads. Immobilized 1810 was expressed in and purified from E. coli. Impor-
tantly, this candidate region of p300 (aa 1135–1810)E1A was incubated with a HeLa nuclear extract for affinity
purification of E1A-associated polypeptides. FLAG-E1A showed significant histone acetyltransferase activity.
For further mapping within this region, a series ofwas then eluted from the beads, along with E1A-associ-
ated polypeptides, by incubating with FLAG-peptide. Al- N-terminal deletions was constructed. Deletion of 60
residues, resulting in a fragment containing aa 1195–though E1A per se has no histone acetyltransferase activ-
ity (data not shown), E1A recruited significant amounts of 1810, had no effect on the acetyltransferase activity,
whereas the deletion of 185 residues, yielding a frag-histone acetyltransferase activity from the nuclear extract
(Figure 1A). It is very unlikely that this activity is derived ment comprising residues 1320–1810, completely elimi-
nated the acetyltransferase activity. Next, we analyzedfrom PCAF given that E1A and PCAF cannot bind to p300/
p300/CBP Is a Histone Acetyltransferase
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a series of C-terminal deletions to determine the require-
ment of the PCAF (or E1A) binding domain. The p300
fragments lacking the E1A binding domain (aa 1195–
1760, 1195–1706, and 1195–1673) still retained the ace-
tyltransferase activity, whereas the further truncated
mutant (aa 1195–1652) completely lost the acetyltrans-
ferase activity. Consistent with these results, the internal
deletion of residues 1418–1720 showed no acetyltrans-
ferase activity. From these data, we conclude that the
histone acetyltransferase domain is located between
the bromodomain and the E1A-binding domain. Given
that the histone acetyltransferase domain is highly con-
served between p300 and CBP (91% similarity), the cor-
responding region of CBP, residues 1174–1850, was
expressed to confirm the acetyltransferase activity. As
expected, comparable activity was detected (data not
shown). Thus, we conclude that both p300 and CBP are
histone acetyltransferases.
Among various acetyltransferases including histone
acetyltransferases GCN5 and PCAF, putative acetyl-
CoA binding sites are conserved (Lu et al., 1996). How-
ever, multiple alignment analysis (Lawrence et al., 1993)
showed that the p300/CBP histone acetyltransferase
domain does not belong to this group. Moreover, com-
parison of the p300/CBP histone acetyltransferase do-
main with peptide sequence databases (Altschul et al.,
1990) showed no obvious sequence similarity to any
other proteins. Accordingly,we conclude that p300/CBP
represents a novel class of acetyltransferases in that it
does not have the conserved motif found among pre-
viously described acetyltransferases (Lu et al., 1996).
p300 Acetylates All Core Histones
in Mononucleosomes
Next, we examined substrate specificity for acetylation
by p300. As substrates, histone octamers and mono-
nucleosomes (146 base pairs of DNA wrapped around
the octamer of core histones) were used. Given that the
histone octamer dissociates into dimers or tetramers
under physiological conditions, we refer here to the his-
tone octamer as core histones. When corehistones were
used, p300 acetylated all four proteins, but preferentially
H3 and H4 (Figure 3A, lane 2). More importantly, in a
nucleosomal context, p300 also acetylated all four core
histones (lane 4). In contrast, p300 acetylated neither
BSA nor lysozyme (data not shown).
Hyperacetylated histones are believed to be linked
with transcriptionally active chromatin (reviewed in
Turner, 1993; Wolffe, 1994; Brownell and Allis, 1996;
Figure 2. Mapping of p300 Histone Acetyltransferase Domain Wolffe and Pruss, 1996). Hyperacetylated forms are
(A) The indicated fragments were expressed in Sf9 cells via a bacu- found in histones H4, H3, and H2B, which have multiple
lovirus expression vector (top). The fragment having significant ace-
acetylation sites in vivo. Next, we tested the level oftyltransferase activity is shaded. Numbers indicate amino acid posi-
acetylation by p300. Mononucleosomes treated withtion of p300 from the N-terminus. The regions that interact with
p300 were analyzed by two-dimensional gel electropho-other transcription factors (reviewed in Introduction) and the bromo-
domain (Haynes et al., 1992) are shown. Although some interactions resis (Figure 3B). A Coomassie blue–stained gel (top)
have been reported for either p300 or CBP only, there is no evidence and the corresponding autoradiogram (bottom) showed
to indicate that there is a specificity between p300 and CBP in that a significant amount of histones, especiallyH4, were
binding with activators. About 1 pmol was used for the histone
hyperacetylated. Importantly, acetylation levels by p300acetyltransferase assays (bottom).
were very close to those of hyperacetylated histones(B) The indicated fragments were expressed in and purified from E.
prepared from HeLa nuclei treated with sodium butyrate,coli (top). The mutants having significant acetyltransferase activity
are shaded. The histone acetyltransferase assay was performed as a histone deacetylase inhibitor (data not shown). In con-
shown in (A) except that about 0.1 pmol was used (bottom). trast, no acetylated forms were detected in the reaction
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without p300 (data not shown; the positions correspond-
ing to the nonacetylated forms are marked). These re-
sults indicate that p300 acetylates histones in mono-
nucleosomes to the hyperacetylated state by targeting
multiple lysine residues.
p300 Acetylates the Four Lysines in the Histone H4
N-Terminal Tail In Vitro That Are Acetylated In Vivo
Lysines at positions 5, 8, 12, and 16 of histone H4 are
acetylated in vivo (reviewed in Brownell and Allis, 1996)
(see Figure 3C, top). Recent studies with yeast histone
acetyltransferases demonstrate the position-specific ace-
tylation by distinct acetyltransferases, i.e., while cyto-
plasmic acetyltransferases for histone deposition and
chromatin assembly modify positions 5 and 12, GCN5
modifies positions 8 and 16 (Kuo et al., 1996). Accordingly,
the positions of acetylation by p300 were also determined
(Figure 3C, bottom). A series of synthetic peptides con-
taining acetylated lysines at various positions was used
to determine the acetylation site-specificity of p300. Con-
sistent with the two-dimensional gel electrophoresis anal-
ysis (Figure 3B), the experiments with peptide substrates
show that p300 acetylates all four lysines in the histone
H4 that are acetylated in vivo. These results are consistent
with the view that deposition-related diacetylated histones
are deacetylated during maturation of chromatin (Shima-
mura and Worcel, 1989).
p300 Preferentially Acetylates
the N-Terminal Histone Tail
Histone acetyltransferases modify specific lysine residues
in the N-terminal tail of core histonesbut not the C-terminal
globular domain in vivo (for reviews, see Turner, 1993;
Wolffe, 1994; Brownell and Allis, 1996; Wolffe and Pruss,
1996). Structural models of nucleosomes (reviewed in
Arents and Moudrianakis, 1993; Ramakrishnan, 1994;
Pruss et al., 1995) suggest that most of the lysine residues
in the C-terminal globular domain are buried. Therefore,
we examined whether restricted acetylationofthe N-termi-
nal tail resulted from the substrate specificity of the en-
zyme or inaccessibility of the enzyme to the core domain
in nucleosomes (Figure 4). The globular domains of all
core histones contain a long helix flanked on either side
by a loop segment and short helix, termed the “histone
fragment of p300 (aa 1135–2414) (lanes 2 and 4). [14C]acetylated
histones were detected by autoradiography after separation by
SDS–PAGE.
(B) Mononucleosomes acetylated by p300 (aa 1135–2414) were sep-
arated by two-dimensional gel analyses. The two-dimensional gel
was stained with Coomassie brilliant blue (top), then [14C]acetylated
histones were detected by autoradiography (bottom). The positions
of nonacetylated forms are marked by ovals. The positions of mono-
(1), di- (2), tri- (3) and tetra- (4) acetylated histone H4 are indicated.
(C) Sites of posttranslational modification of lysine residues by ace-
tylation in vivo are indicated (top). To determine the susceptibility
of individual lysines to acetylation by p300, lysines at the particular
positions were substituted with e-N-acetyllysine during peptide syn-
thesis (bottom). Note that positions of unlabeled e-N-acetyllysine
incorporated during peptide synthesis are indicated. Various pep-
Figure 3. Acetylation Mode by p300
tide substrates were incubated with about 0.1 pmol of the p300
(A) Core histones (lanes 1 and 2) or mononucleosomes (lanes 3 and fragment aa 1195–1706, and [3H]acetyl groups incorporated into
4) were incubated with no enzyme (lanes 1 and 3) or the C-terminal various peptide substrates were determined.
p300/CBP Is a Histone Acetyltransferase
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fold” (reviewed in Arents and Moudrianakis, 1993; Rama- targeted acetylation of active chromatin (Brownell et al.,
1996; Yang et al., 1996). PCAF iscomposed of the PCAF-krishnan, 1994; Pruss et al., 1995). The histone fold is
involved in formation of the stable H2A-H2B and H3-H4 specific region, which interacts directly with p300/CBP
(J. Nishikawa, X.-J. Yang, and Y. N., unpublished data),hetero-dimers, consisting of extensive hydrophobic con-
tacts between the paired molecules. Therefore, it is likely and a GCN5-homologous region having intrinsic histone
acetyltransferase activity (Yang et al., 1996). The presentthat a histone monomer cannot fold properly, thereby in-
creasing access of the histone acetyltransferase to the report, taken together with these findings, supports the
idea that p300/CBP and PCAF could be recruited ontocore domain. Based on these considerations, we tested
whether p300 acetylates free histone H4 in an N-terminal- specific promoters via protein–protein interactions,
thereby contributing to targeted acetylation of specificspecific manner.
Histone H4 was acetylated with p300, and subse- chromatin domains (Figure 5).
An intriguing question is why two histone acetyltrans-quently the histone tail was removed by partial digestion
with trypsin. The distributions of radioactivity between ferases appear to be positioned to function coopera-
tively. A possible explanation is that p300/CBP andintact and core histones were compared. While the glob-
ular core histone domain was predominant at the higher PCAF may have complementary substrate specificities,
each being required to achieve functional acetylationtrypsin concentrations (Figure 4, top, lanes 6 and 7),
radioactivity was detected mostly in the intact histone optimal for activated transcription. While recombinant
PCAF acetylates preferentially histone H3 in mono-(bottom, lanes 6 and 7). Therefore, we conclude that
p300 preferentially acetylates the N-terminal tail of his- nucleosomes (Yang et al., 1996), PCAF forms a complex
with other polypeptides in vivo, which may alter thetone H4.
substrate specificity (R. L. S, X.-J. Yang, Y. N, unpub-
lished data); accordingly, the specificity of PCAF in theDiscussion
native context remains unresolved. On the other hand,
the acetylation profile by p300 is very close to that foundAcetylated histones are a characteristic feature of tran-
scriptionally activechromatin. Hyperacetylated histones in vivo (Figure 3). Moreover, the p300/CBP histone ace-
tyltransferase activity is quite strong, i.e., 1 pmol of E1Aaccumulate within particular active chromatin domains,
whereas hypoacetylated histones accumulate within affinity-purified native p300/CBP produces z500 pmol
of acetylated histones per minute when free histonestranscriptionally silenced domains (reviewed in Turner,
1993; Wolffe, 1994; Brownell and Allis, 1996; Wolffe and are used as substrates. Therefore, p300/CBP per se
may be sufficient, qualitatively, for full acetylation ofPruss, 1996). The recent findings that the transcriptional
regulators GCN5 and PCAF are histone acetyltransfer- nucleosomes.
Alternatively, the two histone acetyltransferases mayases provide new insights into mechanisms involving
each contribute, quantitatively, to the optimal acetyla-
tion of nucleosomes. Presumably, p300/CBP and PCAF
acetylate after binding to promoters in the native con-
text. Given the restricted flexibility of immobilized en-
zymes on promoters, multiple acetyltransferases may
confer the advantage of increasing the number of acces-
sible histones or nucleosomes. p300/CBP and PCAF
may acetylate distinct histone core particles and/or dis-
tinct histones from different angles of the same nucleo-
some (Figure 5). Given that yeast does not have obvious
counterparts to p300/CBP or PCAF, the p300/CBP–
PCAF pathway may have been acquired during meta-
zoan evolution to deal with more tightly packed linker
histone–containing chromatin in metazoan organisms.
A recurrent translocation associated with the M4/M5
subtype of acute myeloid leukemia fuses MOZ and CBP
in-frame (Borrow et al., 1996). Intriguingly, a putative
acetyltransferase domain has been found in MOZ, al-
though MOZ acetyltransferase activity has not been
confirmed experimentally. This raises the possibility of
the MOZ-CBP fusion having two histone acetyltransfer-
ases, acting in concert with PCAF, to mediate transfor-
mation via aberrant histone acetylation. Alternatively,
Figure 4. p300 Preferentially Acetylates the Histone H4 N-Terminal the high conservation between MOZ and the yeast SAS2
Tail silencing gene (Reifsnyder et al., 1996) suggests that
Histone H4 was acetylated with about 0.1 pmol of the p300 fragment the MOZ acetyltransferase may be a multisubstrate
aa 1135–2414 and subsequently digested with trypsin at concentra- N-terminal acetyltransferase modifying the a-amino
tions of 0, 0.5, 1, 2.5, 5, 7.5, and 10 mg/ml (lanes 1–7, respectively).
group, and thus involved in silencing (for review, seeAfter separation by SDS–PAGE, the gel was stained with Coomassie
Loo and Rine, 1995). If this is the case, the MOZ acetyl-brilliant blue (top), then [14C]acetylated fragments were detected by
transferase may functionally oppose to the histone ace-autoradiography (bottom). The positions of intact and core histones
are shown. tyltransferase activities of p300/CBP and PCAF.
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Figure 5. Model of Molecular Functions of
p300/CBP and PCAF
p300/CBP and PCAF form a complex on spe-
cific promoter elements via interaction with
various DNA-binding activators (see Figure
2A), then acetylate histone tails (shown in red)
in a promoter-specific manner. p300/CBP
and PCAF may acetylate synergistically by
targeting distinct histone core particles and/
or distinct histones from different angles on
the same nucleosome. Targeted histone ace-
tylation could contribute to promoter activa-
tion by altering or disrupting the repressive
chromatin structure.
Experimental Procedures (Panyim and Chalkley, 1969) and the second dimension was an
SDS–PAGE gel.
Purification of E1A-Associated Histone Acetyltransferase
FLAG-epitope-tagged E1A (or DE1A) was expressed in Sf9 cells by Protein Expression
infecting recombinant baculovirus (Yang et al., 1996). All purification For baculovirus expression, cDNAs corresponding to the p300 por-
steps were carried out at 48C. Extract was prepared from infected tions shown in Figure 2A were amplified by PCR (Expand High Fidel-
cells by one cycle of freeze and thaw in buffer B (20 mM Tris–HCl ity PCR System; Boehringer Mannheim) as KpnI-NotI fragments.
[pH 8.0]; 5 mM MgCl2; 10% glycerol; 1 mM PMSF; 10 mM b-mercap- The resulting fragments were subcloned into a baculovirus transfer
toethanol; 0.1% Tween 20) containing 0.1 M KCl and the “complete” vector having theFLAG-tag sequence (Yang etal., 1996). The recom-
protease inhibitor cocktail (Boehringer Mannheim). To prepare E1A- binant viruses were isolated using the BaculoGold system (Phar-
immobilized beads, the extract was incubated with M2 anti-FLAG mingen), according to the manufacturer’s protocol, and were in-
antibody agarose (Kodak-IBI) for 4 hr with rotating and subsequently fected into Sf9 cells to express FLAG-p300. Recombinant proteins
washed with the same buffer 3 times. The resulting beads were were affinity purified with M2 anti-FLAG antibody-immobilized aga-
incubated with HeLa nuclear extract for 4 to 8 hr and thereafter rose (Kodak-IBI) according to the manufacturer’s protocol.
washed with the same buffer 6 times. Finally, FLAG-E1A was eluted For bacterial expression, cDNAs encoding the p300 portions
from the beads along with associated polypeptides by incubating shown in Figure 2B and the CBP portion (aa 1174–1850) were first
with the same buffer containing 0.1 mg/ml FLAG-peptide. subcloned into the baculovirus transfer vector having the FLAG-
For further purification, eluted polypeptides were dialyzed in 0.05 tag as described above. Thereafter, the XhoI and NotI fragments
M KCl–buffer B and subsequently loaded onto a SMART Mono Q encoding FLAG-p300 or FLAG-CBP fusions were resubcloned into
column (Pharmacia) equilibrated with the same 0.05 M KCl–buffer the E. coli expression vector pET-28c (Novagene) digested with SalI
B. After washing, the column was developed with a linear gradient and NotI. Recombinant proteins were expressed in E. coli BL21(DE3)
of 0.05–1.0 M KCl in buffer B. Mono Q fractions were concentrated and affinity purified with M2-antibody agarose.
with a Microcon spin-filter (Amicon) and consequently loaded onto
a SMART Superdex 200 column (Pharmacia) equilibrated with 0.1 Acknowledgments
M KCl–buffer B.
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